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Abstract
Background: We aimed to develop and test a literature-based model for symptoms that associate with cardiac
causes of syncope.
Methods and Results: Seven studies (the derivation sample) reporting ≥2 predictors of cardiac syncope were
identified (4 Italian, 1 Swiss, 1 Canadian, and 1 from the United States). From these, 10 criteria were identified as
diagnostic predictors. The conditional probability of each predictor was calculated by summation of the reported
frequencies. A model of conditional probabilities and a priori probabilities of cardiac syncope was constructed. The
model was tested in four datasets of patients with syncope (the test sample) from Calgary (n=670; 21% had cardiac
syncope), Amsterdam (n=503; 9%), Milan (n=689; 5%) and Rochester (3877; 11%). In the derivation sample ten
variables were significantly associated with cardiac syncope: age, gender, structural heart disease, low number of
spells, brief or absent prodrome, supine syncope, effort syncope, and absence of nausea, diaphoresis and blurred
vision. Fitting the test datasets to the full model gave C-statistics of 0.87 (Calgary), 0.84 (Amsterdam), 0.72 (Milan)
and 0.71 (Rochester). Model sensitivity and specificity were 92% and 68% for Calgary, 86% and 67% for Amsterdam,
76% and 59% for Milan, and 73% and 52% for Rochester. A model with 5 variables (age, gender, structural heart
disease, low number of spells, and lack of prodromal symptoms) was as accurate as the total set.
Conclusion: A simple literature-based Bayesian model of historical criteria can distinguish patients with cardiac
syncope from other patients with syncope with moderate accuracy.
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Introduction
The differential diagnosis of syncope is wide, ranging from
vasovagal syncope, to cardiac arrhythmias, orthostatic
hypotension, and valvular heart disease [1]. Among patients
less than 65 years of age, cardiac syncope comprises little
more than one-fifth of causes of syncope, whereas in patients
above 65 years it is the cause of syncope in 42% of cases
[2,3]. Importantly, patients with cardiac syncope are at
increased risk of cardiovascular events and mortality [4].
Several studies have investigated the usefulness of clinical
history and demographics as predictors of the cause of
syncope [5-8]; others have investigated criteria associated with
adverse outcome in syncope patients [9-14]. However, these
studies differ in setting, outcome, definitions, and potential
markers in relation to syncope. The purpose of this study was
to use these publications to develop an international, literature-
based model to predict cardiac syncope. A model for predicting
cardiac syncope based on historical and demographic criteria
that is effective and robust to minor differences in definition and
setting may provide a useful tool for risk stratification of
patients presenting with syncope.
Accordingly, we conducted a literature search to identify
studies reporting historical and demographic variables
associated with cardiac syncope, and combined the reported
results in a conditional probabilities model. We then tested the
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effectiveness of this model against data of patients with
syncope from four centres that were not associated with the
derivation populations.
Methods
Model derivation and model testing were conducted
independently. Two samples of publications were defined.
Publications were included in the derivation sample [5,6,15-19]
if they presented summary findings such as proportions or
sensitivity and specificity, but the patient-specific primary data
sets were not acquired by the investigators. Publications were
included in the test sample if they had summary data, and the
patient-specific primary data sets were acquired by the
investigators [7-9,20,21].
Our intent was to summarize the results from major articles
published in the field. Pubmed was searched for relevant
studies in 2 separate searches. First, the terms “diagnosis”,
“signs and symptoms” and “vasovagal syncope” were entered.
Second, the terms “clinical history”, “diagnosis” and “syncope”
were entered. Resulting abstracts were scanned manually and
studies were included if they featured all of the following:
patients with ≥1 transient loss of consciousness; a diagnosis of
cardiac syncope vs. other causes, according to the degree of
evidence accepted in each paper; and ≥2 historical symptoms
or criteria (not counting results of physical exam or further
diagnostics) reported in relation to the final diagnosis.
Secondary searches were conducted in local bibliographies
and in references from identified articles.
Key variables in the derivation sample
Variables from the 7 derivation populations [5,6,15-19] were
selected as predictors if they were reported to be associated
with specific causes of syncope. Similarities and differences
among the derivation datasets in the prevalence of predictors,
and the relation between predictors and outcome, were
identified using logistic regression models. Some studies
included a range of variables in a multiple logistic regression
model without presenting a cross-tabulation of the presence of
individual variables against the final diagnosis; therefore a
statistically significant association between a predictor and the
diagnosis may have been reported without a quantification of
this association. To ensure data were entered in the model on
all selected predictors, we introduced an arbitrary threshold:
only variables reported to be statistically significantly
associated with the diagnosis (regardless of how the results
are presented), in all patients or among a subgroup of patients,
in ≥3 studies, were included. Signs observed by bystanders
were excluded because they are conditional upon the presence
of bystanders [22].
Model construction in derivation sample
The most important model variables were combined in a
conditional probabilities model. The conditional probabilities of
predictors, given the diagnosis, were derived by summation of
the frequencies reported in each study, whether the association
was reported as statistically significant or not. Associations that
were quantified indirectly (for example from sensitivity and
specificity, or mean and standard deviation) were recalculated
as frequencies, where possible.
The model consists of a graphical structure of nodes,
illustrated in Figure 1. The nodes represent the study
population, cardiac syncope and a range of predictors. The a
priori probability of cardiac syncope corresponded with the
prevalence of cardiac syncope in the study population. The
direction of the arrows indicates that the outcome (cardiac
syncope) is dependent on the predictors (age, gender,
structural heart disease, etc.) For each symptom, the relation
between the symptom and the outcome is characterised by a
conditional probability table: the probability that cardiac
syncope causes the symptom. For example, based on the
literature search we know that the probability of nausea, given
the presence of cardiac syncope, is 8%; the probability of
nausea, given the presence of non-cardiac syncope, is 20%.
The probabilistic information and the node structure are
combined to calculate the probability that a patient suffers from
cardiac syncope, using a joint Bernouilli probability model. The
probability that a patient presenting with a specific set of
historical criteria had cardiac syncope is the normalized
product of the individual conditional probabilities, multiplied by
the prior probability that a random member of the patient
population has cardiac syncope. For each patient, the model
output is within the range of probability of zero and one.
Model description
The accuracy of the model in predicting cardiac syncope was
tested in datasets from 4 independent syncope populations for
whom primary data were available [7-9,20,21]. A graphical
representation of the final model structure is given in Figure 1.
The population node contains 4 categories; one for each test
dataset (Calgary [7,8,20], Amsterdam [21], Milan [9] and
Rochester [2]). Each test dataset corresponds to a data-
derived a priori chance of cardiac syncope. For each test
subject, the prior probability of cardiac syncope, which is
specific to the test population (e.g. 21% in the Calgary data), is
then updated with a posterior probability: the probability of
cardiac syncope given the population as well as the predictors
for that subject.
Testing the Model from the Derivation Sample
For each test dataset, patient data were fitted to the
conditional probabilities model, resulting in a predicted
probability of cardiac syncope for each patient. The predicted
probabilities against the actual diagnoses were displayed in a
receiver operating characteristics (ROC) curve. A c-statistic
was computed to give an overall estimate of how well the
model discriminated cardiac vs. non-cardiac syncope in the test
data.
Parsimonious model
Not all test datasets contained all model variables; therefore,
for a fair comparison of the model efficiency in the 4 test
datasets, model fits were repeated using only the 5 predictors
available in all datasets.
Diagnosis of Syncope by History
PLOS ONE | www.plosone.org 2 September 2013 | Volume 8 | Issue 9 | e75255
Testing the Model using Resampled Data
Among patients who have only fainted once, and among
older patients, historical criteria might be less predictive [17].
Accrual bias might, therefore, have affected the associations
between predictors and outcome. We standardized the
proportion of older patients, and of patients who only fainted
once to attenuate differences due to accrual bias. Each dataset
was resampled to create 1000 samples with a standardized
distribution of age and number of spells (both as categorical
variables), using PROC SURVEYSELECT in SAS. The overall
distribution of age and number of spells reported in the
literature used to build the model was used to create the
standardised distribution. Only variables common to all
datasets were used in the resampled data. Hugin 7.1 was used
to compile the conditional probabilities model, to establish proof
of concept. For computing large datasets, the model was
programmed in Matlab using Kevin Murphy’s Bayes Net
Toolbox (BNT). All other analyses were conducted using SAS
software, version 9.2.
Results
Derivation populations
The literature search identified seven studies [5,6,15-19] that
reported symptoms in relation to cardiac versus non-cardiac
diagnoses (Table 1). Of the 2388 patients 1317 (55%) were
from Italy, 939 (39%) from Switzerland, 80 (3%) from the US
and 52 (2%) from Canada. Only the patients reported by
Galizia et al. [17] were selected based on age; they were at
least 65 years old.
Predictors of cardiac syncope
Eleven variables were statistically significantly associated
with the diagnosis in 3 or more derivation studies listed in Table
1. The resulting conditional probability tables for these
variables are given in Table 2. Palpitations were more common
among cardiac syncope patients in some studies [5,6], and
more common among vasovagal patients in others [15,18].
Overall the association of palpitations with cardiac vs. non-
cardiac syncope was not statistically significant; therefore, this
variable was excluded. The resulting 10 variables associated
with cardiac syncope were age >60 years, male sex, structural
heart disease, <3 spells, and supine syncope and effort
syncope. Factors associated with non-cardiac syncope
included age < 40 years, a long prodrome, nausea,
diaphoresis, and blurred vision. These had moderate accuracy
in identifying patients with cardiac syncope (Figure 2).
Test populations
There were 4 test datasets.
Canada and United Kingdom: Syncope Symptom Study,
‘Calgary data’ [7,8,20]. Between January 1995 and July 2001,
670 patients (age 51±21 years) with at least one loss of
consciousness were recruited from neurology, cardiology,
pacemaker, arrhythmia and syncope clinics. All patients
completed a 118-item questionnaire based on Calkins et al.
[15], assessing symptom burden, provocative situations, peri-
syncopal symptoms, symptoms thought to be associated with
epileptic seizures, signs observed by bystanders and relevant
medical history. Definitions of clinical diagnoses were tightly
and prospectively defined; patients underwent
electrophysiologic studies and where necessary also tilt table
Figure 1.  Schematic representation of the joint probability model structure.  
doi: 10.1371/journal.pone.0075255.g001
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tests (excepting those with a clinically declared cause of
syncope such as sustained VT during syncope) [20]. In total,
138 (21%) patients had cardiac syncope.
Netherlands: Fainting Assessment Study (FAST),
‘Amsterdam data’ [21]. Between February 2000 and May 2002,
503 patients (age 52±19 years) presenting with a transient loss
of consciousness at the neurology, cardiology, and internal
medicine emergency department, or the cardiac emergency
department of the Academic Medical Center in Amsterdam
were enrolled. A standardised medical history was taken, using
a questionnaire based on the European Society of Cardiology
guidelines [1]. Clinical diagnoses were based on expert opinion
after 2 years of follow-up, and documented arrhythmias where
available. A total of 44 (9%) patients had cardiac syncope.
Italy: Short-Term Prognosis of Syncope (STePS) Study,
‘Milan data’ [9]. Between January and July 2004, 689 patients
(age 60±21 years) presenting with syncope at emergency
departments in one of four general hospitals in the Milan area
were enrolled [9]. Cardiac syncope was mainly defined as a
change in rhythm therapy or a documentation of a potential
substrate for syncope. Only 37 (5%) patients had cardiac
syncope.
United States, ‘Rochester data’ [2]. Between January 1996
and December 1998, 3877 patients (age 57±23 years) were
evaluated for syncope at the Mayo Clinic in Rochester, Minn.
Patients were referred from outpatient clinics, inpatient
services, hospital emergency departments and other
institutions. Clinical diagnoses were based on expert opinion,
and documented arrhythmias where available. Cardiac
syncope was defined as a documented symptom-rhythm
correlation, or a potential substrate for syncope. In total, 424
(11%) patients had cardiac syncope.
Distribution of predictors in test populations
The prevalence of predictors in each dataset, and how the
predictors were distributed among patients with cardiac and
non-cardiac symptoms, is shown in Table 3; not all predictors
were surveyed in all centres. Structural heart disease was
common among Calgary (21%) and Milan (25%) patients, but
much less so among Amsterdam (10%) and Rochester patients
Table 1. The seven studies on which the conditional probabilities model was based.
Reference Alboni et al. [5] Calkins et al. [15]
Del Rosso et
al. [16]
Del Rosso et al.
[6] Galizia et al. [17] Iglesias et al. [18] Sud et al. [19]
Patient selection ≥1 LOC ≥1 LOC ≥1 LOC ≥1 LOC ≥1 LOC ≥1 LOC orpresyncope
≥1 LOC with injury or
recurrent LOC
Location Italy US Italy Italy Italy Switzerland Canada
Clinical setting Syncope unit
Patients referred for
evaluation of
syncope
Syncope unit Emergencydepartment
Admitted or
emergency
department
Ambulatory syncope
clinic
Patients undergoing
monitoring for
syncope
Patient exclusion  Sick sinus syndrome  Non-syncopalcause of LOC
Severe cognitive
impairment, active
malignancies,
limitation in activities
of daily living
Seizure, vertigo or
coma
Ejection fraction
<35%
Minimum age for
inclusion ≥18 ≥18  ≥18 ≥65   
Age (mean±SD) 61±20 58±17 <65: 43±16;≥65: 76±7 63±21 79±7 52±21 67±14
Number of patients 341 80 485 260 231 939 52
Main diagnostic
categories        
Cardiac syncope CS AV block; VT CS CS CS Arrhythmia Primary arrhythmic
 n=78 n=16, n=32 n=116 n=44 n=34 n=148 n=20
(Predominantly)
neurally mediated
syncope
Neurally mediated
syncope Vasodepressor VVS Non-CS Non-CS VV/Psy Nonarrhythmia
 n=199 n=32 n=296 n=216 n=174 n=387 n=32
Other
Unexplained/
Neurologic/
Psychiatric
 Unknown  Unknown
Hypotension
Miscellaneous
Unexplained
 
 n=64  n=73  n=23 n=58, n=27, n=319  
VVS= vasovagal syncope, neurally mediated syncope, neurocardiogenic syncope, CS= cardiac syncope, AV = atrioventricular, VT= ventricular tachycardia. LOC= loss of
consciousness.
doi: 10.1371/journal.pone.0075255.t001
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(11%). Other pronounced differences between test datasets
were in age and number of previous spells. Rochester and
Milan patients were older than Calgary and Amsterdam
patients. Having had only two spells or less was most common
in Rochester patients. The median [interquartile range] for the
number of previous spells was 4 [2-20] for Calgary patients, 3
[1-8] for Amsterdam patients and 1 [1,2] for Rochester patients.
Having had a single faint occurred in 19% of Calgary patients,
27% of Amsterdam patients, 43% of Milan patients and 66% of
Rochester patients. Having had at least 10 occurred in 33% of
Calgary patients, 24% of Amsterdam patients, and 5% of
Rochester patients.
Results are given as number (
%) There were statistically significant differences in the
overall prevalence of predictors, between the 4 centres (chi-
square tests, p <0.001 for all symptoms/demographics). *
‘Blurred vision’ was not explicitly asked in the Rochester study.
The term ‘blurred vision’ was extracted from a text field for
patients’ comments. † In the Milan data, the number of spells
was categorised as ‘One spell’ vs. ‘More than one spell’.
Because this was the only information available, it was used as
a proxy for ‘Two spells or less’ vs ‘More than two spells’.
Table 2. Overview of selected published studies: prevalence of selected symptoms in relation to final diagnosis.
 Cardiac syncope Non-cardiac syncope     
Reference [5] [15] [16] [6] [17] [18] [19] Total [5] [15] [16] [6] [17] [18] [19] Total χ2 Test   Likeli-hood ratio
Number of patients 78 48 116 44 34 148 20 488 (21%) 259 32 296 216 174 791 32 1800 (79%) χ2 DF p  
Age                     
<40 years 1* 0* - - - 1* 0* 3 (1%) 50* 13* - - - 259* 1* 234 (29%) 171.7 2 <0.0001 -
40 to 60 years 13 10 - - - 37 5 65 (22%) 89 13 - - - 315 10 427 (38%)     
≥60 years 64 38 - - - 110 15 226 (77%) 120 5 - - - 217 21 363 (33%)     
Gender                     
Male 49 41 - 34 12 90 12 238 (64%) 133 10 - 122 74 388 16 743 (49%) 25.4 1 <0.0001 1.30
Female 29 7 - 10 22 58 8 134 (36%) 126 22 - 94 100 403 16 761 (51%)     
Struc heart disease                     
Yes - - 107 - - - 11 118 (87%) - - 77 - - - 8 85 (26%) 283.7 1 <0.0001 3.00
No - - 9 - - - 9 18 (13%) - - 219 - - - 24 243 (74%)     
Number of spells                     
Two spells or less - 37 77 - - - - 114 (70%) - 4 120 - - - - 124 (38%) 44.0 1 <0.0001 1.84
More than two spells - 11 39 - - - - 50 (30%) - 28 176 - - - - 204 (62%)     
Nausea                     
Yes 4 2 7 - 2 19 - 34 (8%) 34 16 45 - 38 174 - 307 (20%) 32.3 1 <0.0001 1.15
No 74 46 109 - 32 129 - 390 (92%) 225 16 251 - 136 617 - 1245 (80%)     
Diaphoresis                     
Yes 65 41 100 38 32 106 - 86 (18%) 487 14 213 136 124 341 - 753 (43%) 92.6 1 <0.0001 1.42
No 13 7 16 6 2 42 - 382 (82%) 72 18 83 80 50 450 - 1015 (57%)     
(Long) prodrome†                     
Yes 46 9 23 21 4 79 - 182 (39%) 172 21 96 160 57 611 - 1117 (63%) 89.7 1 <0.0001 1.66
No 32 39 93 23 30 69 - 286 (61%) 87 11 200 56 117 180 - 651 (37%)     
Blurred vision                     
Yes 26 6 30 8 1 26 - 97 (21%) 53 12 31 68 45 308 - 517 (29%) 13.5 1 0.0002 1.12
No 52 42 86 36 33 122 - 371 (79%) 206 20 265 148 129 483 - 1251 (71%)     
Palpitations                     
Yes 11 1 13 4 1 9 - 39 (8%) 26 8 38 2 7 119 - 200 (11%) 3.4 1 0.06 1.03
No 67 47 103 40 33 139 - 429 (92%) 233 24 258 214 167 372 - 1568 (89%)     
Supine syncope                     
Yes 9 2 - 6 - - - 17 (10%) 6 0 - 6 - - - 12 (2%) 18.1 1 <0.0001 4.23
No 69 46 - 38 - - - 153 (90%) 253 32 - 210 - - - 495 (98%)     
Syncope during effort                     
Yes 10 - - 6 - - - 16 (13%) 7 - - 2 - - - 9 (2%) 30.5 1 <0.0001 6.92
No 68 - - 38 - - - 106 (87%) 252 - - 214 - - - 466 (98%)     
*. Number of patients per age category was calculated from the reported mean and SD of patients’ age
† Presence or prolonged presence of prodromal symptoms, or awareness of being about to faint
doi: 10.1371/journal.pone.0075255.t002
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Performance of conditional probabilities model in test
populations
Three analyses of the test populations were performed: 1) all
4 test populations; 2) a heavily resampled population to
mitigate data collection biases; and 3) a parsimonious model.
The conditional probabilities model, using all available
information for each dataset, resulted in c-statistics of 0.87 for
the Calgary data [7,8,20], 0.84 for the Amsterdam data [21],
0.72 for the Milan data [9] and 0.71 for the Rochester data [2]
(Figure 3). With a cut-off value of the probability of cardiac
syncope of 0.02 (selected to favour sensitivity over specificity),
the sensitivity and specificity of the full model were 92% and
68% for Calgary, 86% and 67% for Amsterdam, 76% and 59%
for Milan, and 73% and 52% for Rochester. Using only
variables common to all datasets (age, gender, structural heart
disease, number of spells, and prodromal symptoms) a more
parsimonious model resulted in very similar c-statistics of 0.88,
0.83, 0.72 and 0.69, respectively.
In an effort to identify the source of discrepancy in model
accuracy for the 4 test datasets, we sought to reduce accrual
bias by standardizing the distribution of age and number of
spells. The conditional probabilities model on the resampled
data resulted in c-statistics of 0.80 for Calgary, 0.78 for
Amsterdam, 0.73 for Milan and 0.69 for Rochester (Figure 3).
There were great differences among centres in the mean
predicted probability of cardiac syncope among cardiac
syncope patients (Figure 4). However, for all locations, the
predicted probability of cardiac syncope was greater in cardiac
syncope patients than in non-cardiac syncope patients (Mann-
Whitney rank sum test; p<0.001 for all comparisons).
Discussion
We aimed to develop an international, literature-based model
to predict cardiac syncope. This simple model of historical and
demographic criteria distinguishes patients with cardiac
syncope from patients with other causes of syncope, with
accuracy in the range of the Framingham [23] and TIMI [24]
scores. The accuracy of the simple model approaches the
pooled estimates [25] of sensitivity and specificity of the San
Francisco Syncope Rule used in emergency rooms for a
variety of medical outcomes. However, there were differences
between research centres in the predictive power of individual
historical criteria, and therefore also in the predictive power of
the overall model.
The inclusion of only 5 predictor variables preserved the
overall accuracy of the model in all test datasets for cardiac
syncope. They were age over 40 years, male sex, structural
heart disease, no more than 2 spells, and brief or no prodromal
symptoms. The parsimonious model is simpler, and therefore
generally preferable. However it will not perform as well in
specific settings, such as when arrhythmias are suspected in
young people [26]. The summary of predictive powers in Table
2 contains useful data for these particular settings.
This study is the first literature-based model to identify
patients with cardiac syncope based on historical and
demographic criteria. Predictive models are generally data-
driven, and may not be effective in other populations. This
model is based on the results of 7 studies, conducted in 4
countries, and is more likely to be robust. To confirm this,
model testing was performed on independent primary datasets
from 4 countries. A further strength was the use of a conditional
probabilities model taking into account the prior probability of
cardiac syncope. Prior probabilities may differ among locations
(and did), and taking this into account makes the model more
suitable for use in different settings.
The model is surprisingly robust, given the differences
among the derivation and test centres. It serves to identify the
major clinical features that increase the likelihood for cardiac
syncope. The results highlight the importance of male sex,
advancing age, structural heart disease, recent onset, and few
prodromal symptoms in predicting cardiac syncope. The model
accuracy and robustness make it suitable as a risk stratification
tool, although it cannot be reduced to a simple scoring rule.
Clinical use of the model would involve implementation of the
conditional probability tables and model algorithms as a smart-
phone or desktop application, and these variables might also
Figure 2.  Predictors of cardiac syncope in the derivation populations.  
doi: 10.1371/journal.pone.0075255.g002
Diagnosis of Syncope by History
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serve as the basis for development of a future, widely based
score.
Clinical and physiologic features: The predictor variables are
simple, and have familiar clinical and physiologic features. For
example, male sex predicts cardiac syncope, which resonates
with the lower likelihood of males having vasovagal syncope
[27,28]. Advancing age predicts cardiac syncope, and it also
associates with age-dependent diseases such as sick sinus
syndrome, aortic stenosis, and myocardial infarction. Factors
associated with non-cardiac syncope such as age < 40 years, a
long prodrome, nausea, diaphoresis, and blurred vision
resonate strongly with the demographic and clinical features of
vasovagal syncope. The long prodrome and blurred vision is
likely due to the relatively gradual decline of blood pressure,
and the preceding diaphoresis reflects the intense cutaneous
sympathetic activity that occurs with vasovagal syncope.
The complexities of health service and epidemiology studies
of syncope have left the field with several large opportunities,
which have only recently begun to be addressed. The main
issues are the uncommon occurrence of documenting syncope
in the act, the large differential diagnosis with quite varying
severities of outcomes, the heterogeneous substrates that
predispose to it, and the range of outcomes. Compounding this
is a lack of uniform criteria and definitions for diagnosis,
substrates, degree of certainty about diagnosis, variable
approaches to diagnostic investigations, and variable
definitions of outcomes. There are assumptions about the link
between investigation results and true diagnosis, and therefore
ongoing uncertainty that demonstrating electrical or structural
substrates actually establish a diagnosis. As well, the relative
uncommonness of any single diagnosis of any single form of
cardiac syncope often leads to them being pooled together.
With these problems it is not surprising that up to half of
syncope goes undiagnosed in other than specialty centres.
Finally, rare causes of syncope such as genetic arrhythmias do
not figure prominently in most studies because of their rarity.
There have been three approaches to these problems. The
first is to use very rigorous diagnostic criteria for each cause of
syncope, exemplified by the Calgary Syncope Symptom
studies [7,8,20] and the ISSUE ILR studies [29-32]. The
second is to develop uniform criteria for outcomes, as is now
the case for studies of syncope in the emergency department
[33]. This study takes a third approach, more common and
pragmatic, more probabilistic and integrative. It is based on 11
studies, and integrates the assumptions widely made in the
practice of syncope. For example, it implicitly assumes that all
cardiac syncope lacks the autonomic symptoms associated
with vasovagal syncope, and that most vasovagal syncope has
these symptoms. It implicitly assumes, as do its integrated
studies, that identification of a substrate diagnoses the cause
of syncope, and it simply accepts the varied definitions of
cardiac syncope. It also implicitly accepts that not all syncope
can be diagnosed. Although this approach lacks the rigor of
some earlier studies, it has the strength of reflecting current
styles and standards of practice. It also establishes a
foundation for future, more tightly controlled studies.
Figure 3.  Receiver-operator curves (ROC) of the predicted probabilities against the actual outcome, for each
dataset.  Model results are shown using all available variables (closed triangles, solid line), for a parsimonious model using only
variables common to all datasets (age, gender, structural heart disease, number of spells, and prodromal symptoms; open circles,
short dashed line), and for a model using data resampled to create standard distributions of number of spells and age (categorical;
open inverted triangles).
doi: 10.1371/journal.pone.0075255.g003
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Limitations
There are several potential limitations. The model was based
only on the data reported in a sufficient number of 7 studies
[5,6,15-19], raising the possibility of inclusion bias due to the
biases built into the care patterns of the involved health care
systems. For example, a completely publicly funded system
with easy access to health care facilities might increase the a
priori probability of non-cardiac syncope. Second, not all test
datasets included all model variables. Third, although
interactions between variables in relation to the outcome were
tested in logistic regression models (data not shown),
dependence between predictors was not taken into account.
There are differences in terminology among centres in both
derivation and test populations. Of the two studies used to
derive conditional probabilities for structural heart disease, the
Figure 4.  Predicted probability of cardiac syncope
(median, inter-quartile range [box], 10-90th percentile
[whiskers] and outliers [crosses]) using three sampling
methods.  The full model includes all patients with a final
diagnosis of cardiac syncope (C) and non-cardiac syncope
(NC) using the full model; the parsimonious model uses only
the 5 variables common to all datasets; and the resampled
model uses resampled data with standardized distributions of
age and number of spells.
doi: 10.1371/journal.pone.0075255.g004
term ‘heart disease’ was defined by one [19]; but not the other
[16], and the definition “structural heart disease” varied among
the reports. This report suggests the importance of
international agreement on definitions, and for an international
approach [25,33] to the development of decision rules that
work well across all reasonably relevant clinical populations.
Fifth, diagnostic scores are only as good as the clarity and
certainty of the reference diagnoses. The Calgary Syncope
Symptom Study [7,8,20] used very precise a priori definitions,
essentially requiring either a hemodynamically documented
syncopal spell or an induced arrhythmia or faint. Others
included inferential causes, such as sinus bradycardia
documented at another time [2]. Differences in the certainty of
the diagnoses might explain some of the differences among the
model behaviours in the test populations.
Finally, there were differences among test populations in
important variables such as age and number of spells
[2,7-9,20,21]. However, resampling to create standardized
distributions of number of age and spells did not equalize the
model accuracy for the 4 test datasets. Whether other
uncollected factors affect the association between predictors
and diagnosis of cardiac syncope remains unknown.
Conclusion
A literature-based conditional probability model using
information on age, gender, structural heart disease, number of
spells, (long) prodrome, nausea, diaphoresis, blurred vision,
supine syncope and effort syncope identifies patients with
cardiac syncope with moderate accuracy. Future studies might
benefit from providing uniform definitions of predictors and
outcomes, and collecting a wide range of patient characteristics
to take into account inter-centre patient population differences.
Acknowledgements
No other persons have made substantial contributions to the
manuscript.
Author Contributions
Conceived and designed the experiments: JBG AS WW NvD
GC RF WKS RS. Performed the experiments: JBG AS WW
NvD GC RF WKS RS. Analyzed the data: JBG AS WW NvD
GC RF WKS RS. Contributed reagents/materials/analysis
tools: JBG AS RS. Wrote the manuscript: JBG AS WW NvD
GC RF WKS RS.
References
1. Moya A, Sutton R, Ammirati F, Blanc JJ, Brignole M et al. (2009)
Guidelines for the diagnosis and management of syncope (version
2009): the Task Force for the Diagnosis and Management of Syncope
of the European Society of Cardiology (ESC). Eur Heart J 30(21):
2631-2671. doi:10.1093/eurheartj/ehp298. PubMed: 19713422.
2. Chen LYl, Gersh BJ, Hodge DO, Wieling W, Hammill SC et al. (2003)
Prevalence and clinical outcomes of patients with multiple potential
causes of syncope. Mayo Clin Proc 78: 414-420. doi:10.4065/78.4.414.
PubMed: 12683693.
3. Colman N, Nahm K, Ganzeboom KS, Shen WK, Reitsma J et al. (2004)
Epidemiology of reflex syncope. Clin Auton Res 14 Suppl 1: 9-17. doi:
10.1007/s10286-004-1003-3. PubMed: 15480937.
4. Soteriades ES, Evans JC, Larson MG, Chen MH, Chen L et al. (2002)
Incidence and Prognosis of Syncope. N Engl J Med 347: 878-885. doi:
10.1056/NEJMoa012407. PubMed: 12239256.
5. Alboni P, Brignole M, Menozzi C, Raviele A, Del Rosso A et al. (2001)
Diagnostic value of history in patients with syncope with or without
heart disease. J Am Coll Cardiol 37(7): 1921-1928. doi:10.1016/
S0735-1097(01)01241-4. PubMed: 11401133.
Diagnosis of Syncope by History
PLOS ONE | www.plosone.org 9 September 2013 | Volume 8 | Issue 9 | e75255
6. Del Rosso A, Ungar A, Maggi R, Giada F, Petix NR et al. (2008)
Clinical predictors of cardiac syncope at initial evaluation in patients
referred urgently to a general hospital: the EGSYS score. Heart 94(12):
1620-1626. doi:10.1136/hrt.2008.143123. PubMed: 18519550.
7. Sheldon R, Rose S, Connolly S, Ritchie D, Koshman ML et al. (2006)
Diagnostic criteria for vasovagal syncope based on a quantitative
history. Eur Heart J 27(3): 344-350. PubMed: 16223744.
8. Sheldon R, Rose S, Ritchie D, Connolly SJ, Koshman ML et al. (2002)
Historical criteria that distinguish syncope from seizures. J Am Coll
Cardiol 40(1): 142-148. doi:10.1016/S0735-1097(02)01940-X. PubMed:
12103268.
9. Costantino G, Perego F, Dipaola F, Borella M, Galli A et al. (2008)
Short- and long-term prognosis of syncope, risk factors, and role of
hospital admission: results from the STePS (Short-Term Prognosis of
Syncope) study. J Am Coll Cardiol 51(3): 276-283. doi:10.1016/j.jacc.
2007.08.059. PubMed: 18206736.
10. Grossman SA, Fischer C, Lipsitz LA, Mottley L, Sands K et al. (2007)
Predicting adverse outcomes in syncope. J Emerg Med 33(3): 233-239.
doi:10.1016/j.jemermed.2007.04.001. PubMed: 17976548.
11. Martin TP, Hanusa BH, Kapoor WN (1997) Risk stratification of patients
with syncope. Ann Emerg Med 29(4): 459-466. doi:10.1016/
S0196-0644(97)70217-8. PubMed: 9095005.
12. Quinn JV, Stiell IG, McDermott DA, Sellers KL, Kohn MA et al. (2004)
Derivation of the San Francisco Syncope Rule to predict patients with
short-term serious outcomes. Ann Emerg Med 43(2): 224-232. doi:
10.1016/S0196-0644(03)00823-0. PubMed: 14747812.
13. Reed MJ, Newby DE, Coull AJ, Jacques KG, Prescott RJ et al. (2007)
The Risk stratification Of Syncope in the Emergency department
(ROSE) pilot study: a comparison of existing syncope guidelines.
Emerg Med J 24(4): 270-275. doi:10.1136/emj.2006.042739. PubMed:
17384381.
14. Reed MJ, Newby DE, Coull AJ, Prescott RJ, Jacques KG et al. (2010)
The ROSE (risk stratification of syncope in the emergency department)
study. J Am Coll Cardiol 55(8): 713-721. doi:10.1016/j.jacc.
2009.09.049. PubMed: 20170806.
15. Calkins H, Shyr Y, Frumin H, Schork A, Morady F (1995) The value of
the clinical history in the differentiation of syncope due to ventricular
tachycardia, atrioventricular block, and neurocardiogenic syncope. Am
J Med 98(4): 365-373. doi:10.1016/S0002-9343(99)80315-5. PubMed:
7709949.
16. Del Rosso A, Alboni P, Brignole M, Menozzi C, Raviele A (2005)
Relation of clinical presentation of syncope to the age of patients. Am J
Cardiol 96(10): 1431-1435. doi:10.1016/j.amjcard.2005.07.047.
PubMed: 16275193.
17. Galizia G, Abete P, Mussi C, Noro G, Morrione A et al. (2009) Role of
early symptoms in assessment of syncope in elderly people: results
from the Italian group for the study of syncope in the elderly. J Am
Geriatr Soc 57(1): 18-23. doi:10.1111/j.1532-5415.2008.02070.x.
PubMed: 19054186.
18. Iglesias JF, Graf D, Forclaz A, Schlaepfer J, Fromer M (2009) Stepwise
Evaluation of Unexplained Syncope in a Large Ambulatory Population.
Pacing Clin Electrophysiol 32: S202-S206. doi:10.1111/j.
1540-8159.2008.02291.x. PubMed: 19250095.
19. Sud S, Klein GJ, Skanes AC, Gula LJ, Yee R et al. (2009) Predicting
the cause of syncope from clinical history in patients undergoing
prolonged monitoring. Heart Rhythm 6(2): 238-243. doi:10.1016/
j.hrthm.2008.10.035. PubMed: 19187918.
20. Sheldon R, Hersi A, Ritchie D, Koshman ML, Rose S (2010) Syncope
and structural heart disease: historical criteria for vasovagal syncope
and ventricular tachycardia. J Cardiovasc Electrophysiol 21(12):
1358-1364. doi:10.1111/j.1540-8167.2010.01835.x. PubMed:
20586825.
21. van Dijk N, Boer KR, Colman N, Bakker A, Stam J et al. (2008) High
diagnostic yield and accuracy of history, physical examination, and
ECG in patients with transient loss of consciousness in FAST: the
Fainting Assessment study. J Cardiovasc Electrophysiol 19(1): 48-55.
PubMed: 17916139.
22. Thijs RD, Wagenaar WA, Middelkoop HA, Wieling W, van Dijk JG
(2008) Transient loss of consciousness through the eyes of a witness.
Neurology 71(21): 1713-1718. doi:10.1212/01.wnl.
0000335165.68893.b0. PubMed: 19015487.
23. Panel ExpertDetection on E, and Treatment of High Blood Cholesterol
in Adults (2001) Executive Summary of the Third Report of the National
Cholesterol Education Program (NCEP) expert Panel on detection,
evaluation, and treatment of High Blood cholesterol in Adults (Adult
Treatment Panel III). J Am Med Assoc 285:2486-2497
24. Antman EM, Cohen M, Bernink PJLM, McCabe CH, Horacek T et al.
(2000) The TIMI Risk Score for Unstable Angina/Non-ST Elevation MI.
A method for prognostication and therapeutic decision making. J Am
Med Assoc 284: 835-842. doi:10.1001/jama.284.7.835.
25. Saccilotto RT, Nickel CH, Bucher HC, Steyerberg EW, Bingisser R et
al. (2011) San Francisco Syncope Rule to predict short-term serious
outcomes: a systematic review. CMAJ 183(15): E1116-E1126.
PubMed: 21948723.
26. Krahn AD, Healey JS, Simpson CS, Chauhan VS, Birnie DH et al.
(2012) Sentinel symptoms in patients with unexplained cardiac arrest:
from the cardiac arrest survivors with preserved ejection fraction
registry (CASPER). J Cardiovasc Electrophysiol 23(1): 60-66. doi:
10.1111/j.1540-8167.2011.02185.x. PubMed: 21955300.
27. Ganzeboom KS, Colman N, Reitsma JB, Shen WK, Wieling W (2003)
Prevalence and triggers of syncope in medical students. Am J Cardiol
91(8): 1006-1008, A8 doi:10.1016/S0002-9149(03)00127-9. PubMed:
12686351.
28. Serletis A, Rose S, Sheldon AG, Sheldon RS (2006) Vasovagal
syncope in medical students and their first-degree relatives. Eur Heart J
27(16): 1965-1970. doi:10.1093/eurheartj/ehl147. PubMed: 16837484.
29. Brignole M, Menozzi C, Moya A, Garcia-Civera R, Mont L et al. (2001)
Mechanism of Syncope in Patients With Bundle Branch Block and
Negative Electrophysiological Test. Circulation 104(17): 2045-2050.
doi:10.1161/hc4201.097837. PubMed: 11673344.
30. Moya A, Brignole M, Menozzi C, Garcia-Civera R, Tognarini S et al.
(2001) Mechanism of syncope in patients with isolated syncope and in
patients with tilt-positive syncope. Circulation 104(11): 1261-1267. doi:
10.1161/hc3601.095708. PubMed: 11551877.
31. Menozzi C, Brignole M, Garcia-Civera R, Moya A, Botto G et al. (2002)
Mechanism of syncope in patients with heart disease and negative
electrophysiologic test. Circulation 105(23): 2741-2745. doi:
10.1161/01.CIR.0000018125.31973.87. PubMed: 12057988.
32. Brignole M, Moya A, Menozzi C, Garcia-Civera R, Sutton R (2005)
Proposed electrocardiographic classification of spontaneous syncope
documented by an implantable loop recorder. Europace 7(1): 14-18.
doi:10.1016/j.eupc.2004.11.001. PubMed: 15670961.
33. Sun BC, Thiruganasambandamoorthy V, Cruz JD (2012) Standardized
Reporting Guidelines for Emergency Department syncope Risk-
stratification research. Acad Emerg Med 19(6):694-702.
Diagnosis of Syncope by History
PLOS ONE | www.plosone.org 10 September 2013 | Volume 8 | Issue 9 | e75255
